Literature DB >> 21972176

Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples.

Martin Tesli1, Pernille Koefoed, Lavinia Athanasiu, Morten Mattingsdal, Omar Gustafsson, Ingrid Agartz, Lars M Rimol, Andrew Brown, Katrine V Wirgenes, Lisa-Lena Smorr, Anna K Kähler, Thomas Werge, Ole Mors, Erling Mellerup, Erik G Jönsson, Ingrid Melle, Gunnar Morken, Srdjan Djurovic, Ole A Andreassen.   

Abstract

Genetic variants in ankyrin 3 (ANK3) have recently been shown to be associated with bipolar disorder (BD). We genotyped three ANK3 SNPs previously found to be associated with BD (rs10994336, rs1938526, and rs9804190) in a Scandinavian BD case-control sample (N = 854/2,614). Due to evidence of genetic overlap between BD and schizophrenia (SZ), we also genotyped these three SNPs in a Scandinavian SZ case-control sample (N = 1,073/2,919). Combining our Scandinavian samples with an Icelandic sample (N = 435 BD cases, 651 SZ cases, and 11,491 healthy controls), we found rs10994336 and rs9804190 to be nominally significantly associated with BD in this combined Nordic BD sample (N = 1,289/14,105). Nominal P was 0.015/0.018 (fixed/random effect) for rs10994336 (Bonferroni corrected P = 0.044/0.053) and 0.023 for rs9804190 (Bonferroni corrected P = 0.069). None of the SNPs were significantly associated with SZ in the combined Nordic SZ case-control sample (N = 1,724/14,410). These results further support that ANK3 is a susceptibility gene specific to BD and that more than one risk locus is involved.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972176     DOI: 10.1002/ajmg.b.31244

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

Review 1.  Ankyrins: Roles in synaptic biology and pathology.

Authors:  Katharine R Smith; Peter Penzes
Journal:  Mol Cell Neurosci       Date:  2018-05-03       Impact factor: 4.314

Review 2.  Integrative biological analysis for neuropsychopharmacology.

Authors:  Mark R Emmett; Roger A Kroes; Joseph R Moskal; Charles A Conrad; Waldemar Priebe; Fernanda Laezza; Anke Meyer-Baese; Carol L Nilsson
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

3.  A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorder.

Authors:  Minoo Atakhorrami; Simin Rahimi-Aliabadi; Javad Jamshidi; Elham Moslemi; Abolfazl Movafagh; Mina Ohadi; Arash Mirabzadeh; Babak Emamalizadeh; Hamid Ghaedi; Fatemeh Gholipour; Atena Fazeli; Marzieh Motallebi; Shaghayegh Taghavi; Azadeh Ahmadifard; Saeed Mohammadihosseinabad; Amir Ehtesham Shafiei Zarneh; Neda Shahmohammadibeni; Faranak Madadi; Monavvar Andarva; Hossein Darvish
Journal:  J Neural Transm (Vienna)       Date:  2015-09-09       Impact factor: 3.575

4.  The ankyrin-3 gene is associated with posttraumatic stress disorder and externalizing comorbidity.

Authors:  Mark W Logue; Nadia Solovieff; Melanie P Leussis; Erika J Wolf; Efthymia Melista; Clinton Baldwin; Karestan C Koenen; Tracey L Petryshen; Mark W Miller
Journal:  Psychoneuroendocrinology       Date:  2013-06-21       Impact factor: 4.905

5.  Identification of rare nonsynonymous variants in SYNE1/CPG2 in bipolar affective disorder.

Authors:  Sally Isabel Sharp; Jenny Lange; Radhika Kandaswamy; Mazen Daher; Adebayo Anjorin; Nicholas James Bass; Andrew McQuillin
Journal:  Psychiatr Genet       Date:  2017-06       Impact factor: 2.458

6.  Ankyrin 3: genetic association with bipolar disorder and relevance to disease pathophysiology.

Authors:  Melanie P Leussis; Jon M Madison; Tracey L Petryshen
Journal:  Biol Mood Anxiety Disord       Date:  2012-10-01

7.  Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data.

Authors:  Alessia Fiorentino; Niamh Louise O'Brien; Devin Paul Locke; Andrew McQuillin; Alexandra Jarram; Adebayo Anjorin; Radhika Kandaswamy; David Curtis; Robert Alan Blizard; Hugh Malcolm Douglas Gurling
Journal:  Bipolar Disord       Date:  2014-04-10       Impact factor: 6.744

8.  Effects of ANK3 variation on gray and white matter in bipolar disorder.

Authors:  E T C Lippard; K P Jensen; F Wang; J A Y Johnston; L Spencer; B Pittman; J Gelernter; H P Blumberg
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992

9.  Family-based association of an ANK3 haplotype with bipolar disorder in Latino populations.

Authors:  S D Gonzalez; C Xu; M E Ramirez; J M Zavala; R Armas; S A Contreras; J Contreras; A Dassori; R J Leach; D Flores; A Jerez; H Raventós; A Ontiveros; H Nicolini; M Escamilla
Journal:  Transl Psychiatry       Date:  2013-05-28       Impact factor: 6.222

10.  A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation.

Authors:  Elvira Bramon; Matti Pirinen; Amy Strange; Kuang Lin; Colin Freeman; Céline Bellenguez; Zhan Su; Gavin Band; Richard Pearson; Damjan Vukcevic; Cordelia Langford; Panos Deloukas; Sarah Hunt; Emma Gray; Serge Dronov; Simon C Potter; Avazeh Tashakkori-Ghanbaria; Sarah Edkins; Suzannah J Bumpstead; Maria J Arranz; Steven Bakker; Stephan Bender; Richard Bruggeman; Wiepke Cahn; David Chandler; David A Collier; Benedicto Crespo-Facorro; Paola Dazzan; Lieuwe de Haan; Marta Di Forti; Milan Dragović; Ina Giegling; Jeremy Hall; Conrad Iyegbe; Assen Jablensky; René S Kahn; Luba Kalaydjieva; Eugenia Kravariti; Stephen Lawrie; Don H Linszen; Ignacio Mata; Colm McDonald; Andrew McIntosh; Inez Myin-Germeys; Roel A Ophoff; Carmine M Pariante; Tiina Paunio; Marco Picchioni; Stephan Ripke; Dan Rujescu; Heinrich Sauer; Madiha Shaikh; Jessika Sussmann; Jaana Suvisaari; Sarah Tosato; Timothea Toulopoulou; Jim Van Os; Muriel Walshe; Matthias Weisbrod; Heather Whalley; Durk Wiersma; Jenefer M Blackwell; Matthew A Brown; Juan P Casas; Aiden Corvin; Audrey Duncanson; Janusz A Z Jankowski; Hugh S Markus; Christopher G Mathew; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Richard C Trembath; Nicholas W Wood; Ines Barroso; Leena Peltonen; Cathryn M Lewis; Robin M Murray; Peter Donnelly; John Powell; Chris C A Spencer
Journal:  Biol Psychiatry       Date:  2013-07-17       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.